What's in Jonsson Comprehensive Cancer Center's pipeline?

Jonsson Comprehensive Cancer Center has 4 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Jonsson Comprehensive Cancer Center's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jonsson-comprehensive-cancer-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jonsson Comprehensive Cancer Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jonsson Comprehensive Cancer Center pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
androgen deprivation therapy	androgen deprivation therapy	phase 3
trastuxumab	trastuxumab	phase 3			Other
bortezomib + rituximab	bortezomib + rituximab	phase 3	Proteasome inhibitor + monoclonal antibody combination	26S proteasome (bortezomib); CD20 (rituximab)	Oncology

Therapeutic area mix

Other · 2
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Jonsson Comprehensive Cancer Center:

Cite this brief

Drug Landscape (2026). Jonsson Comprehensive Cancer Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jonsson-comprehensive-cancer-center. Accessed 2026-05-17.